Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Spectrin/alpha-actinin	AKAP6 KALRN MACF1	1.69e-04	32	63	3	IPR018159
Domain	SPEC	AKAP6 KALRN MACF1	1.69e-04	32	63	3	SM00150
Domain	TIL	MUC5AC MUC6	7.23e-04	12	63	2	PF01826
Domain	C8	MUC5AC MUC6	7.23e-04	12	63	2	PF08742
Domain	Unchr_dom_Cys-rich	MUC5AC MUC6	8.53e-04	13	63	2	IPR014853
Domain	C8	MUC5AC MUC6	8.53e-04	13	63	2	SM00832
Domain	TIL_dom	MUC5AC MUC6	9.93e-04	14	63	2	IPR002919
Domain	VWD	MUC5AC MUC6	1.30e-03	16	63	2	SM00216
Domain	VWF_type-D	MUC5AC MUC6	1.30e-03	16	63	2	IPR001846
Domain	VWFD	MUC5AC MUC6	1.30e-03	16	63	2	PS51233
Domain	VWD	MUC5AC MUC6	1.30e-03	16	63	2	PF00094
Domain	VWC_out	MUC5AC MUC6	1.85e-03	19	63	2	SM00215
Domain	CT	MUC5AC MUC6	2.48e-03	22	63	2	SM00041
Domain	Spectrin	KALRN MACF1	2.71e-03	23	63	2	PF00435
Domain	Cys_knot_C	MUC5AC MUC6	3.20e-03	25	63	2	IPR006207
Domain	CTCK_2	MUC5AC MUC6	3.20e-03	25	63	2	PS01225
Domain	CYCLINS	CCNT2 CCNB3	4.00e-03	28	63	2	PS00292
Domain	Spectrin_repeat	KALRN MACF1	4.29e-03	29	63	2	IPR002017
Domain	Cyclin_N	CCNT2 CCNB3	5.53e-03	33	63	2	IPR006671
Domain	Cyclin_N	CCNT2 CCNB3	5.53e-03	33	63	2	PF00134
Domain	CYCLIN	CCNT2 CCNB3	7.28e-03	38	63	2	SM00385
Domain	-	CCNT2 CCNB3	8.04e-03	40	63	2	1.10.472.10
Domain	VWF_dom	MUC5AC MUC6	8.84e-03	42	63	2	IPR001007
Domain	Cyclin-like	CCNT2 CCNB3	9.25e-03	43	63	2	IPR013763
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ALMS1 ZCCHC8 LSG1 N4BP2 MACF1 AFDN IRS1 BCAR1 SRRM2 TRIP12 CFAP97 SAMD4A	8.45e-08	861	67	12	36931259
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AKAP6 TTBK2 BMP2K SPIN1 NKAPD1 NFX1 CD55 MACF1 RTN4IP1 ANKRD12 TRIP12 NUP153	9.77e-07	1084	67	12	11544199
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	3.66e-06	2	67	2	28321513
Pubmed	Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs.	MUC5AC MUC6	3.66e-06	2	67	2	9422745
Pubmed	Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.	MUC5AC MUC6	3.66e-06	2	67	2	12360467
Pubmed	Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.	MUC5AC MUC6	3.66e-06	2	67	2	11988092
Pubmed	Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.	WT1 MUC5AC	3.66e-06	2	67	2	19856421
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SHROOM4 SP2 USF3 ALMS1 SACS N4BP2 COL27A1 MACF1	4.83e-06	493	67	8	15368895
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	SP2 COL27A1 HFM1 SRRM2 TRIP12 NUP153	8.98e-06	250	67	6	33536335
Pubmed	Mucin expression in reactive gastropathy: an immunohistochemical analysis.	MUC5AC MUC6	1.10e-05	3	67	2	17227128
Pubmed	Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.	MUC5AC MUC6	1.10e-05	3	67	2	23828549
Pubmed	Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.	MUC5AC MUC6	1.10e-05	3	67	2	18825309
Pubmed	Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.	MUC5AC MUC6	1.10e-05	3	67	2	18300795
Pubmed	A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer.	MUC5AC MUC6	1.10e-05	3	67	2	19924550
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CCNT2 RPS6KA5 ZCCHC8 NFIC AFDN RIPOR1 SRRM2 TRIP12 NUP153	1.73e-05	774	67	9	15302935
Pubmed	Functional proteomics mapping of a human signaling pathway.	ZCCHC8 L1TD1 SECISBP2 MACF1 AFDN HBP1 TRIP12 INVS	1.79e-05	591	67	8	15231748
Pubmed	Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.	MUC5AC MUC6	2.19e-05	4	67	2	33154304
Pubmed	Gastric mucin expression in first-degree relatives of gastric cancer patients.	MUC5AC MUC6	2.19e-05	4	67	2	24901817
Pubmed	Insulin stimulates the tyrosine dephosphorylation of docking protein p130cas (Crk-associated substrate), promoting the switch of the adaptor protein crk from p130cas to newly phosphorylated insulin receptor substrate-1.	IRS1 BCAR1	2.19e-05	4	67	2	9729467
Pubmed	Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).	MUC5AC MUC6	2.19e-05	4	67	2	36367122
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5AC MUC6	2.19e-05	4	67	2	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5AC MUC6	2.19e-05	4	67	2	14984930
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5AC MUC6	2.19e-05	4	67	2	29869461
Pubmed	Interleukin-1 beta and tumor necrosis factor-alpha induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells.	RPS6KA5 MUC5AC	2.19e-05	4	67	2	12690113
Pubmed	Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?	MUC5AC MUC6	2.19e-05	4	67	2	20929551
Pubmed	Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.	MUC5AC MUC6	2.19e-05	4	67	2	24603585
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5AC MUC6	2.19e-05	4	67	2	23807779
Pubmed	MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.	MUC5AC MUC6	2.19e-05	4	67	2	27298226
Pubmed	Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.	MUC5AC MUC6	2.19e-05	4	67	2	17401217
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5AC MUC6	2.19e-05	4	67	2	12676567
Pubmed	Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.	MUC5AC MUC6	2.19e-05	4	67	2	25298197
Pubmed	Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?	MUC5AC MUC6	3.64e-05	5	67	2	22261707
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC5AC MUC6	3.64e-05	5	67	2	16475027
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CCNT2 KALRN SACS ZCCHC8 LSG1 SPIN1 HMGXB4 MACF1 SRRM2 TRIP12	4.04e-05	1082	67	10	38697112
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	IRS1 BCAR1 SRRM2 SAMD4A	4.64e-05	102	67	4	15778465
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	KALRN ZCCHC8 AFDN BCAR1 SRRM2 TRIP12 NUP153	5.22e-05	503	67	7	16964243
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC5AC MUC6	5.46e-05	6	67	2	19110483
Pubmed	Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2 and mucins.	MUC5AC MUC6	5.46e-05	6	67	2	17982272
Pubmed	Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore.	NFX1 NUP153	1.02e-04	8	67	2	31375530
Pubmed	Anchoring and scaffold proteins for kinases and phosphatases.	AKAP6 AKAP10	1.30e-04	9	67	2	9238861
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ALMS1 NFX1 SECISBP2 MACF1 NUP153	1.57e-04	263	67	5	34702444
Pubmed	AKAP mediated signal transduction.	AKAP6 AKAP10	1.63e-04	10	67	2	11807172
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MEAF6 NFIC SPIN1 NKAPD1 ZNF280C HMGXB4 TRIP12	1.69e-04	608	67	7	36089195
Pubmed	A catalogue of genes in mouse embryonal carcinoma F9 cells identified with expressed sequence tags.	SP2 L1TD1	1.99e-04	11	67	2	8743579
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	AKAP6 ANK2 KALRN MACF1	2.12e-04	151	67	4	17043677
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MEAF6 ALMS1 CCNB3 ZCCHC8 LSG1 HMGXB4 L1TD1 MACF1 SRRM2	2.81e-04	1116	67	9	31753913
Pubmed	Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling.	TTBK2 INVS	2.81e-04	13	67	2	22863007
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	SACS MACF1 SRRM2	4.34e-04	76	67	3	27542412
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ANK2 KALRN GPR158 LSG1 N4BP2 MACF1 AFDN NUP153	5.16e-04	963	67	8	28671696
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC5AC MUC6	5.48e-04	18	67	2	18834073
Pubmed	Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb.	BMP2K SRRM2	5.48e-04	18	67	2	23211419
Pubmed	De novo lumen formation and elongation in the developing nephron: a central role for afadin in apical polarity.	WT1 AFDN	5.48e-04	18	67	2	23487309
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	MIGA2 ALMS1 BMP2K ZCCHC8 LSG1 NFX1 SECISBP2 RTN4IP1 SRRM2 USP33	5.58e-04	1496	67	10	32877691
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	CCNT2 BMP2K MACF1 SRRM2	5.79e-04	197	67	4	20811636
Pubmed	Independent functions and mechanisms for homeobox gene Barx1 in patterning mouse stomach and spleen.	WT1 MUC5AC	6.12e-04	19	67	2	17855428
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	HMGXB4 MACF1 SRRM2 TRIP12 NUP153	6.68e-04	361	67	5	26167880
Pubmed	Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.	OFCC1 IRS1	7.50e-04	21	67	2	22479202
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 ANK2 KALRN SACS ZCCHC8 MACF1 AFDN TRIP12 USP33	7.77e-04	1285	67	9	35914814
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	AKAP6 ZNF573 GPR50 NFIC SECISBP2 AKAP10 ZNF79 ANKRD12 INVS	8.12e-04	1293	67	9	15342556
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MEAF6 SP2 ZCCHC8 NFIC HMGXB4 SRRM2 TRIP12 NUP153 SAMD4A	8.16e-04	1294	67	9	30804502
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	SPIN1 AFDN RIPOR1 AKAP10 USP33	8.21e-04	378	67	5	34315543
Pubmed	The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.	WT1 IRS1 TRIP12	9.39e-04	99	67	3	19730683
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ALMS1 ZCCHC8 N4BP2 SECISBP2 MACF1 BCAR1	9.49e-04	588	67	6	38580884
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	AKAP6 ALMS1 GPR158 MACF1	9.50e-04	225	67	4	12168954
Pubmed	Quantitative trait loci for obesity- and diabetes-related traits and their dietary responses to high-fat feeding in LGXSM recombinant inbred mouse strains.	GPR50 CD55	9.82e-04	24	67	2	15561968
Pubmed	Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.	MUC5AC MUC6	1.07e-03	25	67	2	34391772
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	ALMS1 KALRN SRRM2 USP33	1.08e-03	233	67	4	37704626
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	AKAP6 ALMS1 SRRM2	1.08e-03	104	67	3	9205841
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MACF1 RIPOR1 ANKRD12 SRRM2 USP33	1.14e-03	407	67	5	12693553
Pubmed	Alternatively spliced isoforms of WT1 control podocyte-specific gene expression.	WT1 CD55	1.34e-03	28	67	2	25993318
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	USF3 WT1 BCAR1 TRIP12 NUP153	1.45e-03	430	67	5	35044719
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	AFDN IRS1 SRRM2 SAMD4A	1.51e-03	255	67	4	15324660
Pubmed	Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.	ANK2 KALRN	1.54e-03	30	67	2	20080650
Pubmed	DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC.	LSG1 SRRM2 NUP153	1.56e-03	118	67	3	37105989
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZCCHC8 MACF1 AFDN SRRM2 TRIP12 NUP153	1.62e-03	653	67	6	22586326
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	ALMS1 MACF1 BCAR1	1.63e-03	120	67	3	31413325
Pubmed	Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.	CD55 C1RL	1.64e-03	31	67	2	19344414
Pubmed	SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome.	IRS1 BCAR1	1.75e-03	32	67	2	22974441
Pubmed	A census of human transcription factors: function, expression and evolution.	SP2 USF3 NFIC NFX1 WT1 HBP1 LHX8	1.80e-03	908	67	7	19274049
GeneFamily	CD molecules\|Mucins	MUC5AC MUC6	9.76e-04	21	40	2	648
GeneFamily	Cyclins	CCNT2 CCNB3	1.74e-03	28	40	2	473
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP6 AKAP10	1.87e-03	29	40	2	396
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SP2 ZNF573 ZNF486 ZNF474 WT1 ZNF79	4.66e-03	718	40	6	28
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	DNAJC4 SACS	5.26e-03	49	40	2	584
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CD55 C1RL	7.05e-03	57	40	2	1179
GeneFamily	Ankyrin repeat domain containing	ANK2 ANKRD12 INVS	1.63e-02	242	40	3	403
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	CCNT2 MIGA2 ALMS1 KALRN NFIC COL27A1 HBP1 AKAP10 IRS1 ANKRD12 BCAR1 INVS	1.73e-05	1102	66	12	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	CCNT2 MIGA2 ALMS1 KALRN NFIC COL27A1 HBP1 AKAP10 IRS1 ANKRD12 BCAR1 INVS	2.11e-05	1124	66	12	MM1070
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000	ADAMTSL1 ANK2 RPS6KA5 CD55 IRS1 ANKRD12 TRIP12	2.79e-05	288	65	7	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	NFIC SECISBP2 IRS1 ANKRD12 CFAP97	1.16e-05	199	66	5	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CCNB3 GPR158 L1TD1 MUC6	8.27e-05	155	66	4	8dab23aad905cc35a35643baa0554acb3f6fe6c8
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CCNB3 GPR158 L1TD1 MUC6	8.27e-05	155	66	4	42533beaded07068f00540de704de07e4f19abcf
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	USF3 MACF1 RIPOR1 CFAP97	8.27e-05	155	66	4	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA5 N4BP2 AKAP10 SAMD4A	8.69e-05	157	66	4	370f44047ef438b8f1124c2c2761c150c0d8c57f
ToppCell	Severe-B_naive-1\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	USF3 MACF1 RIPOR1 CFAP97	9.13e-05	159	66	4	2881b054bbeb479221ee3c38bbd9b0815b123579
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADAMTSL1 WT1 C1RL MUC6	1.10e-04	167	66	4	d50311b1f66f143bae4c4cf50e2e9b13c85d6920
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADAMTSL1 WT1 C1RL MUC6	1.10e-04	167	66	4	7abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCell	343B-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	ZNF573 GPR158 COL27A1 L1TD1	1.15e-04	169	66	4	e68e6c24606fd46eca6f86bb63fa86ea17879ae2
ToppCell	Control-B_naive-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	USF3 MACF1 RIPOR1 CFAP97	1.21e-04	171	66	4	d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AKAP6 ADAMTSL1 KALRN SACS	1.26e-04	173	66	4	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANK2 BMP2K SPIN1 SAMD4A	1.32e-04	175	66	4	1d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANK2 BMP2K SPIN1 SAMD4A	1.32e-04	175	66	4	427a7ee92fe16a90625946492062d37aa0f7235b
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AKAP6 SACS WT1 C1RL	1.44e-04	179	66	4	adf8b025032a03dbb58871a92025cd7efbeb22ff
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SACS PI16 WT1 CD55	1.47e-04	180	66	4	c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KALRN MACF1 AFDN BCAR1	1.50e-04	181	66	4	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KALRN COL27A1 IRS1 SAMD4A	1.54e-04	182	66	4	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CD55 MACF1 SRRM2	1.54e-04	182	66	4	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CD55 MACF1 SRRM2	1.57e-04	183	66	4	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CD55 MACF1 SRRM2	1.57e-04	183	66	4	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD55 SRRM2 MUC5AC MUC6	1.60e-04	184	66	4	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	SECISBP2 AFDN SRRM2 CFAP97	1.63e-04	185	66	4	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	CCNT2 NFX1 MACF1 INVS	1.67e-04	186	66	4	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Microfold_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL27A1 MUCL3 MUC5AC MUC6	1.67e-04	186	66	4	6d8dd6d0403d149cb6edb346581fe6c248036785
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KALRN MACF1 AFDN BCAR1	1.67e-04	186	66	4	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 KALRN NUP153 SAMD4A	1.81e-04	190	66	4	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 KALRN NUP153 SAMD4A	1.81e-04	190	66	4	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD55 SRRM2 MUC5AC MUC6	1.81e-04	190	66	4	3c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD55 SRRM2 MUC5AC MUC6	1.81e-04	190	66	4	23f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	SHROOM4 ADAMTSL1 CD55 AFDN	1.85e-04	191	66	4	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTSL1 ANK2 PI16 WT1	1.88e-04	192	66	4	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	ADAMTSL1 ANK2 PI16 WT1	1.88e-04	192	66	4	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K PI16 MACF1 SRRM2	1.92e-04	193	66	4	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTSL1 ANK2 PI16 WT1	1.92e-04	193	66	4	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K PI16 MACF1 SRRM2	1.92e-04	193	66	4	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K PI16 MACF1 SRRM2	1.92e-04	193	66	4	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K PI16 MACF1 SRRM2	1.92e-04	193	66	4	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	IPF-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	ADAMTSL1 PI16 CD55 SAMD4A	1.96e-04	194	66	4	da3e1d39575969a069ef43e552afe94b2f441d0b
ToppCell	COPD-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	ADAMTSL1 PI16 CD55 SAMD4A	2.04e-04	196	66	4	4930eeb303d174c28fd91021723e26fdf1af9170
ToppCell	Control-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	ANK2 PI16 CD55 SAMD4A	2.08e-04	197	66	4	64cc5f61c88e9560b0f8f6f3151255dffb5c3d66
ToppCell	COPD-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	ANK2 PI16 WT1 SAMD4A	2.12e-04	198	66	4	2f13c0b3372af53d1bd85f9546f315c878580a71
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	SPIN1 ANKRD12 TRIP12 CFAP97	2.16e-04	199	66	4	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SHROOM4 ANK2 PI16 BCAR1	2.16e-04	199	66	4	6fb5f931e6217142de38c1fffc011e63bda4772b
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SHROOM4 ANK2 PI16 BCAR1	2.16e-04	199	66	4	5d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	CD55 SECISBP2 ANKRD12 TRIP12	2.16e-04	199	66	4	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	SPIN1 CD55 ANKRD12 TRIP12	2.16e-04	199	66	4	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SHROOM4 ANK2 PI16 BCAR1	2.16e-04	199	66	4	1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SHROOM4 ANK2 PI16 BCAR1	2.16e-04	199	66	4	9dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTSL1 ANK2 PI16 SAMD4A	2.20e-04	200	66	4	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTSL1 ANK2 PI16 WT1	2.20e-04	200	66	4	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MACF1 ANKRD12 SRRM2 TRIP12	2.20e-04	200	66	4	12f1685ce8f218433068e090c9d839cd5a1910bf
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZNF573 NFIC HMGXB4 WT1 RIPOR1 SRRM2	9.95e-06	170	66	6	3791_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NFIC SPIN1 HMGXB4 IRS1 SRRM2 SAMD4A	1.06e-05	172	66	6	1072_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZCCHC8 SPIN1 HMGXB4 WT1 SNUPN SRRM2	1.29e-05	178	66	6	5086_DN
Drug	scriptaid; Down 200; 10uM; PC3; HT_HG-U133A	CCNT2 NFIC HMGXB4 RIPOR1 IRS1 SRRM2	1.47e-05	182	66	6	6896_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NFIC HMGXB4 WT1 AKAP10 SNUPN SRRM2	1.56e-05	184	66	6	7555_DN
Drug	ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA	CCNT2 BMP2K NFX1 AFDN MUC6 SAMD4A	2.17e-05	195	66	6	866_UP
Drug	Edrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HG-U133A	RPS6KA5 LSG1 NFIC MACF1 AKAP10 ANKRD12	2.23e-05	196	66	6	1936_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; PC3; HT_HG-U133A	DNAJC4 WT1 C1RL MUC5AC INVS SAMD4A	2.23e-05	196	66	6	7137_UP
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; HL60; HT_HG-U133A	CCNT2 ANK2 ALMS1 NFIC WT1 SECISBP2	2.36e-05	198	66	6	1853_DN
Drug	Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ALMS1 RPS6KA5 BMP2K RIPOR1 ZNF79 ANKRD12	2.43e-05	199	66	6	6244_DN
Drug	Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	TTBK2 ZNF573 RPS6KA5 RIPOR1 ANKRD12 SAMD4A	2.43e-05	199	66	6	7414_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NFIC HMGXB4 WT1 SNUPN SRRM2	1.11e-04	163	66	5	7285_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZNF573 NFIC IRS1 SRRM2 SAMD4A	1.14e-04	164	66	5	4388_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZNF573 NFIC HMGXB4 IRS1 SRRM2	1.18e-04	165	66	5	6085_DN
Drug	Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A	CCNT2 RPS6KA5 ZCCHC8 HBP1 ANKRD12	1.21e-04	166	66	5	5324_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZNF573 NFIC HMGXB4 WT1 SRRM2	1.35e-04	170	66	5	3746_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SPIN1 HMGXB4 IRS1 SRRM2 SAMD4A	1.43e-04	172	66	5	2794_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NFIC HMGXB4 IRS1 SRRM2 SAMD4A	1.55e-04	175	66	5	1014_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	ZCCHC8 NFIC HMGXB4 IRS1 SAMD4A	1.59e-04	176	66	5	981_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CCNT2 HMGXB4 WT1 IRS1 SNUPN	1.59e-04	176	66	5	4632_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NFIC HMGXB4 WT1 IRS1 SRRM2	1.59e-04	176	66	5	6546_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	ZNF573 NFIC HMGXB4 IRS1 SRRM2	1.63e-04	177	66	5	6434_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ZNF573 HMGXB4 AKAP10 IRS1 SRRM2	1.68e-04	178	66	5	4710_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NFIC SPIN1 HMGXB4 IRS1 SRRM2	1.68e-04	178	66	5	1112_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NFIC SPIN1 HMGXB4 IRS1 SRRM2	1.68e-04	178	66	5	6276_DN
Drug	5224221; Up 200; 12uM; MCF7; HT_HG-U133A_EA	ZNF573 ZCCHC8 NFX1 CD55 SAMD4A	1.72e-04	179	66	5	839_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NFIC HMGXB4 WT1 C1RL SRRM2	1.77e-04	180	66	5	5981_DN
Drug	Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	RPS6KA5 CD55 RIPOR1 HBP1 ANKRD12	1.77e-04	180	66	5	7420_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NFIC SPIN1 NFX1 IRS1 SAMD4A	1.81e-04	181	66	5	6951_DN
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	CCNT2 NFX1 CD55 HBP1 SAMD4A	1.81e-04	181	66	5	1236_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A	NFIC WT1 SNUPN SRRM2 NUP153	1.86e-04	182	66	5	1951_DN
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	ZCCHC8 NKAPD1 HMGXB4 IRS1 ANKRD12	1.91e-04	183	66	5	7062_DN
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A	BMP2K CD55 SECISBP2 ZNF79 MUC5AC	1.91e-04	183	66	5	7059_UP
Drug	0175029-0000 [211245-78-2]; Down 200; 10uM; PC3; HT_HG-U133A	ZCCHC8 HMGXB4 HBP1 ANKRD12 NUP153	1.96e-04	184	66	5	3691_DN
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	ZCCHC8 HMGXB4 IRS1 NUP153 SAMD4A	2.01e-04	185	66	5	1114_DN
Drug	Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A	CCNT2 ZCCHC8 CD55 ZNF79 SAMD4A	2.01e-04	185	66	5	4128_UP
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	ALMS1 RPS6KA5 NFX1 CD55 HBP1	2.06e-04	186	66	5	4463_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	DNAJC4 RPS6KA5 CD55 HBP1 SAMD4A	2.06e-04	186	66	5	6987_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	ZNF573 HMGXB4 WT1 IRS1 SRRM2	2.06e-04	186	66	5	6874_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CCNT2 HMGXB4 WT1 SNUPN SRRM2	2.11e-04	187	66	5	6671_DN
Drug	Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A	CCNT2 ZCCHC8 HMGXB4 IRS1 NUP153	2.16e-04	188	66	5	3291_DN
Drug	H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A	CCNT2 ZCCHC8 HMGXB4 IRS1 ANKRD12	2.22e-04	189	66	5	5936_DN
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	ALMS1 MACF1 RIPOR1 ZNF79 ANKRD12	2.33e-04	191	66	5	4168_DN
Drug	Hexetidine [141-94-6]; Up 200; 11.8uM; PC3; HT_HG-U133A	NFX1 CD55 ZNF79 SRRM2 SAMD4A	2.33e-04	191	66	5	6319_UP
Drug	Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ZNF573 RPS6KA5 BMP2K CD55 RIPOR1	2.44e-04	193	66	5	6485_DN
Drug	Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A	CCNT2 ZNF573 ALMS1 ZNF79 SAMD4A	2.44e-04	193	66	5	3474_UP
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	CD55 SECISBP2 HBP1 C1RL MUC5AC	2.50e-04	194	66	5	1239_UP
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ZNF573 RPS6KA5 BMP2K NFX1 SRRM2	2.56e-04	195	66	5	3191_DN
Drug	S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; HL60; HT_HG-U133A	CCNT2 DNAJC4 RIPOR1 ZNF79 IRS1	2.62e-04	196	66	5	3094_DN
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	TTBK2 ZNF573 RPS6KA5 BMP2K SECISBP2	2.62e-04	196	66	5	7200_UP
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	CCNT2 DNAJC4 ZNF573 MUC6 SAMD4A	2.62e-04	196	66	5	5230_UP
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF573 BMP2K RIPOR1 AKAP10 ANKRD12	2.62e-04	196	66	5	3199_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; PC3; HT_HG-U133A	CCNT2 WT1 RIPOR1 ZNF79 SRRM2	2.62e-04	196	66	5	5751_DN
Drug	Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A	CCNT2 RPS6KA5 NKAPD1 CD55 RIPOR1	2.62e-04	196	66	5	7432_UP
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	CCNT2 RPS6KA5 BMP2K AKAP10 ZNF79	2.69e-04	197	66	5	5341_DN
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A	BMP2K NFX1 RIPOR1 AKAP10 ANKRD12	2.69e-04	197	66	5	6017_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	BMP2K NFX1 ZNF79 SRRM2 SAMD4A	2.69e-04	197	66	5	5493_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A	KALRN NFX1 AFDN RIPOR1 SAMD4A	2.69e-04	197	66	5	3209_UP
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; HL60; HT_HG-U133A	ALMS1 BMP2K NFIC NFX1 AKAP10	2.75e-04	198	66	5	2333_DN
Drug	(+/-)-thalidomide; Down 200; 100uM; MCF7; HG-U133A	ZNF573 ANK2 KALRN ANKRD12 SRRM2	2.75e-04	198	66	5	266_DN
Drug	Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CD55 SECISBP2 RIPOR1 AKAP10 ANKRD12	2.75e-04	198	66	5	6271_DN
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	TTBK2 ZNF573 ALMS1 NFX1 SAMD4A	2.75e-04	198	66	5	4991_DN
Drug	Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; HL60; HG-U133A	ANK2 BMP2K NFX1 CD55 SECISBP2	2.81e-04	199	66	5	1600_UP
Drug	Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; MCF7; HT_HG-U133A	DNAJC4 ZNF573 BMP2K MACF1 RIPOR1	2.81e-04	199	66	5	7016_UP
Drug	Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SP2 ALMS1 RPS6KA5 RIPOR1 SNUPN	2.81e-04	199	66	5	6214_DN
Drug	CAY10397; Down 200; 10uM; MCF7; HT_HG-U133A	BMP2K SPIN1 NFX1 ZNF79 ANKRD12	2.81e-04	199	66	5	7082_DN
Drug	Diflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A	CCNT2 ZNF573 RPS6KA5 MACF1 SAMD4A	2.88e-04	200	66	5	1490_DN
Drug	Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A	AKAP6 DNAJC4 NFX1 AKAP10 MUC5AC	2.88e-04	200	66	5	4787_UP
Disease	mucinous adenocarcinoma (is_marker_for)	MUC5AC MUC6	4.76e-05	5	65	2	DOID:3030 (is_marker_for)
Disease	sleep quality	AKAP6 C1orf87 OFCC1 SAMD4A	1.36e-04	118	65	4	EFO_0005272
Disease	octanoylcarnitine measurement	COL27A1 LHX8	1.70e-04	9	65	2	EFO_0021042
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6	4.27e-04	14	65	2	DOID:10808 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	AKAP6 ANK2 KALRN N4BP2 C1orf87 WT1 MACF1 BCAR1 FSCB	5.55e-04	1074	65	9	C0006142
Disease	birth weight, parental genotype effect measurement	USF3 COL27A1 WT1 BCAR1	8.63e-04	192	65	4	EFO_0004344, EFO_0005939
Disease	Ovarian Failure, Premature	WT1 HFM1	9.77e-04	21	65	2	C0085215
Disease	intelligence, response to cranial radiation therapy	OFCC1 WT1	1.74e-03	28	65	2	EFO_0004337, EFO_0010950
Disease	Intellectual Disability	AKAP6 SHROOM4 SACS ZCCHC8 MACF1	3.06e-03	447	65	5	C3714756

Protein segments in the cluster

Peptide	Gene	Start	Entry
TLDHTGHTSSKSLPN	PI16	386	Q6UXB8
HLNHSSKSVTPASTL	AFDN	1321	P55196
THKAGSSKHHGPIST	CCNT2	411	O60583
GSGKSKHSSPHISRD	CCNT2	541	O60583
SPSSKSSKKHVSGIT	CFAP97	201	Q9P2B7
PAKQTSTFSKQTPHH	BCAR1	141	P56945
ASISVHSPQKSTKNH	AKAP10	46	O43572
ATPTVLSSSHSHRGK	ALMS1	566	Q8TCU4
TSLHLFHISTGKSPK	ANKRD12	531	Q6UB98
HSGSPEKKAEHSSIN	BMP2K	686	Q9NSY1
KSNGKRHHGTPTSTK	BMP2K	991	Q9NSY1
LRKTESHGTHSQSTP	C1orf87	276	Q8N0U7
KSQSSKIVPSHHDPS	CCNB3	16	Q8WWL7
HSPASSSSKTEKHSP	ANK2	1866	Q01484
KHTSTGTRTPVAHTT	MUC6	1941	Q6W4X9
KVSVSATPGHTKHFQ	LSG1	411	Q9H089
KSSSPKATHRIGNTS	FSCB	21	Q5H9T9
SAHNLSSEKKTGHPR	GPR158	881	Q5T848
SVFSHSKAASGHLKP	GPR50	406	Q13585
SHSKSAFSAATSHPK	GPR50	486	Q13585
TTKHFHETTPNKGSG	CD55	336	P08174
TLSPHKHVSGFSSSL	ADAMTSL1	1131	Q8N6G6
VSNNKTPHSSSISHI	KALRN	726	O60229
HSYHPSGSKPKSQQT	NFX1	71	Q12986
TTSTKKSGGASVVPH	KCT2	91	Q8NC54
KKHVSPNHSSSTPVT	LHX8	281	Q68G74
IEPSKHSGSSHSVAS	MIGA2	126	Q7L4E1
SSSHSHGKTTPTKTL	RPS6KA5	766	O75582
HLSVSKTTHSQPVTS	MUC5AC	4611	P98088
PSKKTGEKSSGSSSH	HMGXB4	126	Q9UGU5
HSAGTSPTITHQKTP	IRS1	526	P35568
THLKAEPLTKATHSS	MACF1	546	Q9UPN3
PSHSSVISQHSKGSK	MRPS36	46	P82909
HSKHSDISTIAGPNK	HFM1	1116	A2PYH4
PGSSNKSHEIHKEAS	OFCC1	151	Q8IZS5
TQPSSENKTAHLHKG	C1RL	141	Q9NZP8
KSPRTTVHDKSAHQT	DNAJC4	106	Q9NNZ3
SHASKPASARTSTHK	COL27A1	466	Q8IZC6
KPQKAASSTSSGSHH	MEAF6	151	Q9HAF1
HSSGTVSATSPNKCK	HBP1	421	O60381
KLAKHHSSTTGTPSS	ENAM	1061	Q9NRM1
SGRESHKTSSKHQSP	SACS	4281	Q9NZJ4
TTTHKESAGKKHITP	MUCL3	146	Q3MIW9
PSKGTSGTKSTKHSV	INVS	986	Q9Y283
VSHKPKSLTHTQAAS	RTN4IP1	166	Q8WWV3
SRQSHSSSSPHPKVK	SRRM2	831	Q9UQ35
SKSLSTSHLPGLTTH	SHROOM4	781	Q9ULL8
TSHLPGLTTHSNKTF	SHROOM4	786	Q9ULL8
HIIHPTQKSKASQGS	SECISBP2	356	Q96T21
LEHLSTPKLKGSSHS	SNUPN	336	O95149
LPSTSSSGSKRHKSG	NFIC	271	P08651
HKSKKGQASSPSHVT	AKAP6	601	Q13023
TSPQVKSSTHESRKH	NKAPD1	136	Q6ZUT1
GVKSGNKRSSSHSSP	ZCCHC8	411	Q6NZY4
TTGSKLFQHQKTHTG	ZNF573	396	Q86YE8
APTPAKASAHTKAHT	SPEM3	286	A0A1B0GUW6
TSHKKHRSSVGPSKP	SPIN1	31	Q9Y657
APHLSGTSKKHSAAI	SP2	391	Q02086
SSTSAPTIKGIDHSH	SPATA31D1	336	Q6ZQQ2
SLHHHSASTKTPQGK	TTBK2	1221	Q6IQ55
HTRTHTGKTSEKPFS	WT1	401	P19544
TNIPHSSSATATKVH	USF3	301	Q68DE3
HSLSQHTATSSKKPA	NUP153	216	P49790
APHSNSSDHLTGLKK	ZNF474	196	Q6S9Z5
HSSSSSKGIKSEPHS	ZNF280C	66	Q8ND82
QSPSTSKAHTRKSGA	TRIP12	126	Q14669
THTTTGSTHKPIIST	RIPOR1	571	Q6ZS17
SSFTTHKKIHSGEKP	ZNF486	251	Q96H40
SSLSQHQKSHTGEKP	ZNF79	206	Q15937
TSTILSGQAHHSPLK	SAMD4A	236	Q9UPU9
AKLHSSSHPTSIVKA	USP33	516	Q8TEY7
KHSHTNLSISTGVTK	L1TD1	571	Q5T7N2
KKSHGQHTSLPLTFT	N4BP2	966	Q86UW6